NATURE’S SUNSHINE PRODUCTS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $130.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-11.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2020-03-11
- 2019-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $130.00K.
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $224.00K.
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $186.00K.
- 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $155.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2019-12-31 | $130.00K 10-K · filed 2020-03-11 |
| 2018-12-31 | $224.00K 10-K · filed 2019-03-08 |
| 2017-12-31 | $186.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | $155.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |